header
Local cover image
Local cover image
Image from OpenLibrary

Effect of prebiotic on disposition and tissue residues of tylvalosin in apparently healthy and Mycoplasma gallisepticum infected broiler chickens / Ammar Haki Salman ; Supervised Amer Ramadan Ali Ayad , Salah Eldin Abdelhamid Mohamed Youssef , Ahmed Mohamed Galal Mohamed

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Ammar Haki Salman , 2017Description: 148 P. : charts , facsimiles ; 25cmOther title:
  • تأثير البريبايوتك على المسار الحركي و البقايا للتيلفالوسين في الدجاج السليم و المصاب بالميكوبلازما جليسيبتكم في دجاج التسمين [Added title page title]
Subject(s): Online resources: Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (Ph.D.) - Cairo University - Faculty of Veterinary Medicine - Department of Veterinary Pharmacology Summary: A study of tylvalosin pharmacokinetics was conducted in healthy, health pretreated with prebiotic, Mycoplasma gallisepticum-infected and Mycoplasma gallisepticum-infected pretreated with prebiotic broiler chickens. Tylvalosin was administered intravenously and orally as a single dose of (25 mg/kg b.wt.) to determine its concentrations in blood as well as its kinetic disposition, the oral dose was repeated for 5 consecutive days to determine the tissues residues. The serum concentration - time curve indicated a two-compartment open model. Following intravenous injection, the mean elimination half-lives (t1/2{uF062}) of (6.666±0.285, 6.501±1.143, 3.048±0.232 and 4.284±0.204 h) The apparent volume of distribution (Vd(area)) of tylvalosin was (3.802±0.148, 6.362±0.390, 0.657±0.367 and 6.080±2.928 L/Kg) with body clearance CLÝ (0.953±0.040,1.792±0.062, 1.976±0.743 and 3.592±0.532 L/kg/h) with mean of MRT was (9.314±0.407, 7.533±0.735, 1.739±0.779 and 4.853±0.388 h) in four groups, respectively. Following oral administration, tylvalosin was absorbed with (t{u00BD}Ü) of (0.963±0.045, 0.906±0.025, 0.958±0.207 and 0.956±0.030 h) with peak serum concentration (Cmax) of (1.226±0.024, 0.873±0.009, 0.0760±0.024 and 0.854±0.020 og/ml) at (tmax) of (1.723±0.041, 1.441±0.023, 1.310±0.055 and 1.472±0.025 h) and eliminated with (t{u00BD}Ý) of (3.504±0.049, 3.600±0.165, 3.862±0.103 and 3.132±0.114 h) in four groups, respectively. The systemic bioavailability of Tylvalosin (F%) following oral administration was (47.491±0.538, 52.853±0.416, 72.96±0.003 and 88.652±6.714 %) in four groups, respectively. After single intravenous and oral dose the highest level of drug was concentrated in lung tissue comparable with other tissues, and after repeated oral doses the drug was still detected in lung tissue after 196 hour of the last dose while it is not detected in other tissues
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.10.15.Ph.D.2017.Am.E (Browse shelf(Opens below)) Not for loan 01010110072715000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.10.15.Ph.D.2017.Am.E (Browse shelf(Opens below)) 72715.CD Not for loan 01020110072715000

Thesis (Ph.D.) - Cairo University - Faculty of Veterinary Medicine - Department of Veterinary Pharmacology

A study of tylvalosin pharmacokinetics was conducted in healthy, health pretreated with prebiotic, Mycoplasma gallisepticum-infected and Mycoplasma gallisepticum-infected pretreated with prebiotic broiler chickens. Tylvalosin was administered intravenously and orally as a single dose of (25 mg/kg b.wt.) to determine its concentrations in blood as well as its kinetic disposition, the oral dose was repeated for 5 consecutive days to determine the tissues residues. The serum concentration - time curve indicated a two-compartment open model. Following intravenous injection, the mean elimination half-lives (t1/2{uF062}) of (6.666±0.285, 6.501±1.143, 3.048±0.232 and 4.284±0.204 h) The apparent volume of distribution (Vd(area)) of tylvalosin was (3.802±0.148, 6.362±0.390, 0.657±0.367 and 6.080±2.928 L/Kg) with body clearance CLÝ (0.953±0.040,1.792±0.062, 1.976±0.743 and 3.592±0.532 L/kg/h) with mean of MRT was (9.314±0.407, 7.533±0.735, 1.739±0.779 and 4.853±0.388 h) in four groups, respectively. Following oral administration, tylvalosin was absorbed with (t{u00BD}Ü) of (0.963±0.045, 0.906±0.025, 0.958±0.207 and 0.956±0.030 h) with peak serum concentration (Cmax) of (1.226±0.024, 0.873±0.009, 0.0760±0.024 and 0.854±0.020 og/ml) at (tmax) of (1.723±0.041, 1.441±0.023, 1.310±0.055 and 1.472±0.025 h) and eliminated with (t{u00BD}Ý) of (3.504±0.049, 3.600±0.165, 3.862±0.103 and 3.132±0.114 h) in four groups, respectively. The systemic bioavailability of Tylvalosin (F%) following oral administration was (47.491±0.538, 52.853±0.416, 72.96±0.003 and 88.652±6.714 %) in four groups, respectively. After single intravenous and oral dose the highest level of drug was concentrated in lung tissue comparable with other tissues, and after repeated oral doses the drug was still detected in lung tissue after 196 hour of the last dose while it is not detected in other tissues

Issued also as CD

There are no comments on this title.

to post a comment.

Click on an image to view it in the image viewer

Local cover image